Q BioMed Inc Announces Acquisition of Cancer Pain Drug Metastron(TM) from GE Healthcare
Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries in Which Metastron is Already Registered and Approved for Sale
NEW YORK, November 28, 2018 -- (Healthcare Sales & Marketing Network) -- ... Biopharmaceuticals, Oncology, Acquisitions Q BioMed, GE Healthcare, Metastron
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Marketing | Mergers and Aquisitions | Pain | Pharmaceuticals